BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 32070319)

  • 1. Impact of sarcomatoid differentiation and rhabdoid differentiation on prognosis for renal cell carcinoma with vena caval tumour thrombus treated surgically.
    Yang B; Xia H; Xu C; Lu M; Zhang S; Wang G; Ma L
    BMC Urol; 2020 Feb; 20(1):14. PubMed ID: 32070319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma.
    Kara O; Maurice MJ; Zargar H; Malkoc E; Akca O; Andrade HS; Ramirez D; Caputo PA; Nelson RJ; Rini B; Kaouk JH
    Int Urol Nephrol; 2016 Aug; 48(8):1253-1260. PubMed ID: 27215555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical Management and Oncologic Outcomes of Renal Cell Carcinoma and Inferior Vena Caval Thrombi With Aggressive Histologic Variants.
    Lewis KC; Werneburg GT; Dewitt-Foy ME; Lundy SD; Eltemamy M; Murthy PB; Przybycin CG; Campbell SC; Weight C; Krishnamurthi V
    Urology; 2024 Feb; 184():128-134. PubMed ID: 37925024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of E-Cadherin and β-Catenin as Prognostic Factor in Renal Cell Carcinoma with Tumor Thrombus of the Vena Cava.
    Spachmann PJ; Breyer J; Kalogirou C; Lausenmeyer EM; Weber F; Prohaska S; Denzinger S; Burger M; Kübler H; Otto W; Vergho D
    Urol Int; 2019; 102(4):413-420. PubMed ID: 30844790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal vein and vena cava involvement does not affect prognosis in patients with renal cell carcinoma.
    Ficarra V; Righetti R; D'Amico A; Rubilotta E; Novella G; Malossini G; Mobilio G
    Oncology; 2001; 61(1):10-5. PubMed ID: 11474242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical complexity and prognostic outcome of small volume renal cell carcinoma with high-level venous tumor thrombus and large volume renal cell carcinoma with low-level thrombus.
    Liu Z; Zhao X; Zhang HX; Li LW; Tang SY; Wang GL; Zhang SD; Wang SM; Ma LL; Tian XJ
    Chin Med J (Engl); 2019 Aug; 132(15):1780-1787. PubMed ID: 31306232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologic outcomes following surgical resection of renal cell carcinoma with inferior vena caval thrombus extending above the hepatic veins: a contemporary multicenter cohort.
    Haddad AQ; Wood CG; Abel EJ; Krabbe LM; Darwish OM; Thompson RH; Heckman JE; Merril MM; Gayed BA; Sagalowsky AI; Boorjian SA; Margulis V; Leibovich BC
    J Urol; 2014 Oct; 192(4):1050-6. PubMed ID: 24704115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative metastatic status, level of thrombus and body mass index predict overall survival in patients undergoing nephrectomy and inferior vena cava thrombectomy.
    Spiess PE; Kurian T; Lin HY; Rawal B; Kim T; Sexton WJ; Pow-Sang JM
    BJU Int; 2012 Dec; 110(11 Pt B):E470-4. PubMed ID: 22519938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Microscopic Wall Invasion of the Renal Vein or Inferior Vena Cava on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus: A Multi-institutional Analysis from the International Renal Cell Carcinoma-Venous Thrombus Consortium.
    Rodriguez Faba O; Linares E; Tilki D; Capitanio U; Evans CP; Montorsi F; Martínez-Salamanca JI; Libertino J; Gontero P; Palou J
    Eur Urol Focus; 2018 Apr; 4(3):435-441. PubMed ID: 28753848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus.
    Abel EJ; Spiess PE; Margulis V; Master VA; Mann M; Zargar-Shoshtari K; Borregales LD; Sexton WJ; Patil D; Matin SF; Wood CG; Karam JA
    J Urol; 2017 Aug; 198(2):281-288. PubMed ID: 28268170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel prognostic model for patients with sarcomatoid renal cell carcinoma.
    Zhang BY; Thompson RH; Lohse CM; Leibovich BC; Boorjian SA; Cheville JC; Costello BA
    BJU Int; 2015 Mar; 115(3):405-11. PubMed ID: 24730416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal cell carcinoma with tumor thrombus growing against the direction of venous return: an indicator of complicated surgery and poor prognosis.
    Liu Z; Li Y; Zhao X; Ge L; Zhu G; Hong P; Tang S; Zhang S; Tian X; Wang S; Liu C; Zhang H; Ma L
    BMC Surg; 2021 Dec; 21(1):443. PubMed ID: 34963464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cell carcinoma and tumour thrombus in the inferior vena cava: clinical outcome of 98 consecutive patients and the prognostic value of preoperative parameters.
    Niedworok C; Dörrenhaus B; Vom Dorp F; Piotrowski JA; Tschirdewahn S; Szarvas T; Rübben H; Schenck M
    World J Urol; 2015 Oct; 33(10):1541-52. PubMed ID: 25433505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and oncological outcomes in Chinese patients with renal cell carcinoma and venous tumor thrombus extension: single-center experience.
    Chen X; Li S; Xu Z; Wang K; Fu D; Liu Q; Wang X; Wu B
    World J Surg Oncol; 2015 Feb; 13():14. PubMed ID: 25650039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of venous tumour thrombus consistency (solid vs friable) on cancer-specific survival in patients with renal cell carcinoma.
    Bertini R; Roscigno M; Freschi M; Strada E; Angiolilli D; Petralia G; Matloob R; Sozzi F; Capitanio U; Da Pozzo LF; Colombo R; Guazzoni G; Cremonini A; Montorsi F; Rigatti P
    Eur Urol; 2011 Aug; 60(2):358-65. PubMed ID: 21640483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bland thrombus association with tumour thrombus in renal cell carcinoma: analysis of surgical significance and role of inferior vena caval interruption.
    Ayyathurai R; Garcia-Roig M; Gorin MA; González J; Manoharan M; Kava BR; Soloway MS; Ciancio G
    BJU Int; 2012 Dec; 110(11 Pt B):E449-55. PubMed ID: 22540981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Important surgical considerations in the management of renal cell carcinoma (RCC) with inferior vena cava (IVC) tumour thrombus.
    Lawindy SM; Kurian T; Kim T; Mangar D; Armstrong PA; Alsina AE; Sheffield C; Sexton WJ; Spiess PE
    BJU Int; 2012 Oct; 110(7):926-39. PubMed ID: 22540179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.
    Kim KH; You D; Jeong IG; Kwon TW; Cho YM; Hong JH; Ahn H; Kim CS
    BJU Int; 2012 Dec; 110(11 Pt B):E673-8. PubMed ID: 22973869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus.
    Lambert EH; Pierorazio PM; Shabsigh A; Olsson CA; Benson MC; McKiernan JM
    Urology; 2007 Jun; 69(6):1054-8. PubMed ID: 17572185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.